Results 31 to 40 of about 6,136 (223)
„Cognitive Enhancement" or non-evidence-based nootropic abuse? – Use of Piracetam in Hungary
Cardiologia HungaricaPiracetam has been available on the market since 1971. Its primary indication is the age-related memory decline. The objective of this review is to highlight the controversies surrounding in the use of piracetam.
András Érszegi +4 more
doaj +1 more source
Effects of parenteral papaverine and piracetam administration on cochlea following acoustic trauma
Noise and Health, 2018 Introduction: Noise exposure, the main cause of hearing loss in countries with lot of industries, may result both in temporary or permanent hearing loss.
Nurcan Yurtsever Kum +5 more
doaj +1 more source
, 2018 We present a novel approach to efficiently implement thermal expansion in the quasi-harmonic approximation (QHA) for both isotropic and more importantly, anisotropic expansion.
Abraham, Nathan S., Shirts, Michael R.
core +2 more sources
Neuropharmacological aspects of cognitive neurorehabilitation in epilepsy. [PDF]
, 2006 The role of CNS neuromodulators in cognitive neurorehabilitation can be related to two main issues: 1) the negative impact on cognition of drug categories prescribed for different neurologic symptoms, such as spasticity, extrapyramidal symptoms, or ...
Mula, M, Trimble, MR
core +4 more sources
Neurobehavioral Impacts of Xylazine and Piracetam Interaction on NADH Oxidase in the Rat Brain
Kufa Journal for Veterinary Medical SciencesIn the present study, the effects of different doses of xylazine combined with piracetam were investigated through different behavioral experiments. Xylazine is alpha 2 adrenergic agonist a veterinary sedative, and analgesic agent.
Shaker M. Kermasha +1 more
doaj +1 more source
Piracetam for acute ischaemic stroke [PDF]
Cochrane Database of Systematic Reviews, 2002 Piracetam has neuroprotective and antithrombotic effects which may help to reduce death and disability in people with acute stroke.The objective of this review was to assess the effects of piracetam in acute presumed ischaemic stroke.We searched the Cochrane Stroke Review Group trials register, Medline (from 1965), Embase (from 1980), BIDIS ISI (from ...
Stefano, Ricci +3 more
openaire +5 more sources
Epilepsy in dentatorubral–pallidoluysian atrophy: A systematic review and meta‐analysis
Epilepsia, EarlyView.Summary of key clinical and electrophysiological characteristics of DRPLA‐related epilepsy from a systematic review and meta‐analysis of 1,191 patients. DRPLA patients with epilepsy showed earlier disease onset, longer CAG repeat expansion, and a tendency toward paternal inheritance. EEG findings frequently included photoparoxysmal responses.
Toru Horinouchi +10 more
wiley +1 more source
Improvement of post-hypoxic action myoclonus with levetiracetam add-on therapy: A case report [PDF]
, 2014 Introduction. Chronic post-anoxic myoclonus, also known as Lance-Adams syndrome, may develop following hypoxic brain injury, and is resistant to pharmacological therapy. Case report.
Božić Ksenija +4 more
core +1 more source
Treatment approaches in posthypoxic myoclonus: A narrative review with expert opinion
Epilepsia, EarlyView.Abstract Acute posthypoxic myoclonus (PHM) is a neurological complication that typically emerges within 12–48 h following cardiac arrest, often in comatose patients. It can present as generalized, multifocal, or focal myoclonus and has traditionally been associated with poor prognosis.
Marina Romozzi +7 more
wiley +1 more source
Molecules, 2018 Advanced Glycation End-Products (AGEs) are created in the last step of protein glycation and can be a factor in aging and in the development or worsening of many degenerative diseases (diabetes, chronic kidney disease, atherosclerosis, Alzheimer’s ...
Agnieszka Szkudlarek +2 more
doaj +1 more source